Skip to main content
logo
Biomark Diagnostics Inc. (FRA:20B)
Germany flag Germany · Delayed Price · Currency is EUR
0.3180
0.00 (0.00%)
Last updated: Jul 28, 2026, 8:02 AM CET

Biomark Diagnostics Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
341417101121
Market Cap Growth
74.17%-15.29%61.96%-7.18%-45.46%140.92%
Enterprise Value
341518121221
Last Close Price
0.320.140.190.130.140.27

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
PS Ratio
594.01145.04152.12100.50356.91-
PB Ratio
107.3012.85-40.73-13.42-24.67-386.98
P/TBV Ratio
107.3012.85----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
EV/Sales Ratio
-154.52161.35110.73393.16-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Debt / Equity Ratio
1.400.64-2.54-1.44-3.09-12.70
Net Debt / Equity Ratio
-1.13-0.78-2.28-1.37-2.49-1.61
Net Debt / EBITDA Ratio
0.290.67-0.82-0.86-1.24-0.12
Net Debt / FCF Ratio
0.281.24-1.41-1.72-1.25-0.16
Asset Turnover
0.060.070.180.140.04-
Quick Ratio
1.202.140.160.060.310.98
Current Ratio
1.202.140.160.080.331.00
Return on Equity (ROE)
--340.70%----
Return on Assets (ROA)
-81.70%-60.59%-117.29%-104.38%-66.20%-80.77%
Return on Capital Employed (ROCE)
-218.40%-107.60%1099.30%197.40%4328.70%-3366.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Earnings Yield
-3.12%-8.62%-5.75%-11.94%-9.27%-3.57%
FCF Yield
-3.76%-4.90%-3.98%-5.96%-8.06%-2.64%
Buyback Yield / Dilution
84.66%-6.67%-2.97%-6.22%-6.31%-2.82%